Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review Article · Übersichtsarbeit

Honey: A Natural Remedy for Eye Diseases

Majtanova N.a · Cernak M.a · Majtan J.b,c

Author affiliations

aDepartment of Ophthalmology, University Hospital and Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia; bLaboratory of Molecular Apidology and Apitherapy, Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia; cDepartment of Microbiology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia

Related Articles for ""

Forsch Komplementmed 2016;23:364-369

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Review Article · Übersichtsarbeit

Published online: November 03, 2016
Issue release date: December 2016

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: https://www.karger.com/CMR

Abstract

Honey has been considered as a therapeutic agent; its successful application in the treatment of non-healing infected wounds has promoted its further clinical usage for treating various disorders including eye disorders. There is evidence that honey may be helpful in treating dry eye disease, post-operative corneal edema, and bullous keratopathy. Furthermore, it can be used as an antibacterial agent to reduce the ocular flora. This review discusses both the current knowledge of and new perspectives for honey therapy in ophthalmology.

© 2016 S. Karger GmbH, Freiburg


References

  1. Jankauskiene J, Jarushaitiene D, Cheksteryte V, Rachys J: Using 20% honey solution eye drops in patients with dry eye syndrome. J Apic Res 2007;46:232-235.
  2. Albietz JM, Lenton LM: Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea 2006;25:1012-1019.
  3. Sethi HS, Rai HK: Bullous keratopathy treated with honey. Acta Ophthalmol Scand 2005;83:263-263.
  4. Mozherenkov VP, Prokofjeva GL: Apiterpiia glaznykh zabolevanii (Apitherapy of eye diseases). Vestn Oftalmol 1991;107:73-75.
  5. Al-Waili NS: Investigating the antimicrobial activity of natural honey and its effects on the pathogenic bacterial infections of surgical wounds and conjunctiva. J Med Food 2004;7:210-222.
  6. Majtanova N, Vodrazkova E, Kurilova V, Horniackova M, Cernak M, Cernak A, Majtan J: Complementary treatment of contact lens-induced corneal ulcer using honey: a case report. Contact Lens Anterior Eye 2014;38:61-63.
  7. West ESB, Behrens A, McDonnell PJ, Tielsch JM, Schein OD: The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 2005;112:1388-1394.
  8. Benz MS, Scott IU, Flynn Jr HW, Unonius N, Miller D: Endophthalmitis isolates and antibiotic sensitives: a 6-year review of culture-proven cases. Am J Ophthalmol 2004;137:38-42.
  9. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn Jr HW: In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 2006;124:479-483.
  10. Miyanaga M, Nejima R, Miyai T, Miyata K, Ohashi Y, Inoue Y, Toyokawa M, Asari S: Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones. J Cataract Refract Surg 2009;35:1970-1978.
  11. Park SH, Lim JA, Choi JS, Kim KA, Joo CK: The resistance patterns of normal ocular bacterial flora to four fluoroquinolone antibiotics. Cornea 2009;28:68-72.
  12. McDonald M, Blondeau JM: Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg 2010;36:1588-1598.
  13. Cernak M, Majtanova N, Cernak A, Majtan J: Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery. Phytother Res 2012;26:613-616.
  14. Hori Y, Maeda N, Sakamoto M, Koh S, Inoue T, Tano Y: Bacteriologic profile of the conjuctiva in the patients with dry eye. Am J Ophthalmol 2008;146:729-734.
  15. Hori Y, Maeda N, Sakamoto M, Inoue T, Tano Y: Fluoroquinolone-resistant bacteria and methicillin-resistant staphylococci from normal preoperative conjuctiva. J Cataract Refract Surg 2008;34:711-712.
  16. Jenkins RE, Cooper R: Synergy between oxacillin and Manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrob Chemother 2012;67:1405-1407.
  17. Liu M, Lu J, Müller P, Turnbull L, Burke CM, Schlothauer RC, Carter DA, Whitchurch CB, Harry EJ: Antibiotic-specific differences in the response of Staphylococcus aureus to treatment with antimicrobials combined with Manuka honey. Front Microbiol 2015;5:1-8.
  18. Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, Whitchurch CB, Harry EJ: Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS ONE 2013;8:e57679.
  19. Shimmura S, Shimazaki J, Tsubota K: Results of population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea 1999;18:408-411.
  20. Lemp MA: Management of dry eye disease. Am J Manag Care 2008;14:S88-S101.
  21. Albietz JM, Bruce AS: The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments. Curr Eye Res 2001;22:8-18.
  22. Goldberg I, Graham SL, Crowston JG, D'Mellow G: Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease. Clin Exp Ophthalmol 2015;43:214-220.
  23. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC: Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010;29:618-621.
  24. De Saint Jean M, Brignole P, Bringuier AF, Bauchet A, Feldmann G, Baudouin C: Effects of benzalkonium chloride on growth and survival of Chang conjuctival cells. Invest Ophthalmol Vis Sci 1999;40:619-630.
  25. Tonks A, Cooper RA, Price AJ, Molan PC, Jones KP: Stimulation of TNF-alpha release in monocytes by honey. Cytokine 2001;14:240-242.
  26. Bashkaran K, Zunaina E, Bakiah S, Sulaiman SA, Sirajudeen K, Naik V: Anti-inflammatory and antioxidant effects of Tualang honey in alkali injury on the eyes of rabbits: experimental animal study. BMC Complement Altern Med 2011;11:90.
  27. Uwaydat S, Jha P, Tytarenko R, Brown H, Wiggins M, Bora PS, Bora NS: The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model. Curr Eye Res 2011;36:787-796.
  28. Karabulut E, Durgun T, Durmus AS: Use of honey in treatment of cornea alkali burns. Indian Vet J 2004;81:993-994.
  29. Salehi A, Jabarzare S, Neurmohamadi M, Kheiri S, Rafieian-Kopaei M: A double blind clinical trial on the efficacy of honey drop in vernal keratoconjunctivitis. Evid Based Complement Alternat Med 2014;2014:287540.
  30. Eye Disease Prevalence Group: Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572.
  31. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M: Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Biochem Pharmacol 1982;31:3807-3822.
  32. De Santis L: New horizons in the medical therapy of cataract: aldose reductase inhibitors and other agents. Pharm Int 1986;7:17-20.
  33. Varma SD, Kinoshita JH: Inhibition of lens aldose reductase by flavonoids - their possible role in the prevention of diabetic cataracts. Biochem Pharmacol 1976;25:2505-2513.
  34. Varma SD, Mizuno A, Kinoshita JH: Diabetic cataracts and flavonoids. Science 1977;195:205-206.
  35. Shimizu M, Ito T, Terashima S, Hayashi T, Arisawa M, Morita N, Surokawa S, Ito K, Hashimoto Y: Inhibition of lens aldose reductase by flavonoids. Phytochemistry 1984;23:1885-1888.
  36. Vit P, Jacob TJ: Putative anticataract properties of honey studied by the action of flavonoids on a lens culture model. J Health Sci 2008;54:196-202.
  37. Golychev VN: Use of honey in conservative treatment of senile cataracts. Vestn Oftalmol 1990;106:59-62.
  38. Zarbin MA: Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004;122:598-614.
  39. Age-Related Eye Disease Study Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamin C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001;119:1416-1436.
  40. Goncalves ED, Campos M, Paris F, Gomes JAP, de Farias CC: Bullous keratopathy: etiopathogenesis and treatment. Arq Bras Oftalmol 2009;71:61-64.
  41. Knezovic I, Dekaris I, Gabric N, Cerovski J, Barisic A, Bosnar D, Rastegorac P, Parac A: Therapeutic efficacy of 5% NaCl hypertonic solution in patients with bullous keratopathy. Coll Antropol 2006;30:405-408.
  42. Mansour AM: Epithelial corneal oedema treated with honey. Clin Exp Ophthalmol 2002;30:149-150.
  43. Mansour AM, Zein W, Haddad R, Khoury J: Bullous keratopathy treated with honey. Acta Ophthalmol Scand 2004;82:312-313.
  44. Albietz JM, Lenton LM: Standardised antibacterial Manuka honey in the management of persistent post-operative corneal oedema: a case series. Clin Exp Optom 2015;98:464-472.
  45. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E: Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 2008;46:3774-3779.
  46. Truchado P, Lopez-Galvez F, Gil MI, Tomas-Barberan FA, Allende A: Quorum sensing inhibitory and antimicrobial activities of honeys and the relationship with individual phenolics. Food Chem 2009;115:1337-1344.
  47. Silici S, Sagdic O, Ekici L: Total phenolic content, antiradical, antioxidant and antimicrobial activities of rhododendron honeys. Food Chem 2010;121:238-243.
  48. Alvarez-Suarez JM, Tulipani S, Diaz D, Estevez Y, Romandini S, Giampieri F, Damiani E, Astolfi P, Bompadre S, Battino M: Antioxidant and antimicrobial capacity of several monofloral Cuban honeys and their correlation with color, polyphenol content and other chemical. Food Chem Toxicol 2010;48:2490-2499.
  49. Rhone M, Basu A: Phytochemicals and age-related eye diseases. Nutr Rev 2008;66:465-472.
  50. Srirangam R, Hippalgaonkar K, Avula B, Khan IA, Majumdar S: Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin. J Ocul Pharmacol Ther 2012;28:618-627.
  51. Lin J, Sun J, Wang Y, Ma Y, Chen W, Zhang Z, Gui G, Lin B: Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits. J Ocul Pharmacol Ther 2015;31:51-56.
  52. Oh HN, Kim CE, Lee JH, Yang JW: Effects of quercetin in a mouse model of experimental dry eye. Cornea 2015;34:1130-1136.
  53. Blanco AR, Sudano-Roccaro A, Spoto GC, Nostro A, Rusciano D: Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob Agents Chemother 2005;49:4339-4343.
  54. Vikram A, Jayaprakasha GK, Jesudhasan PR, Pillai SD, Patil BS: Suppression of bacterial cell-cell signalling, biofilm formation and type III secretion system by citrus flavonoids. J Appl Microbiol 2010;109:515-527.
  55. Socha R, Juszczak L, Pietrzyk S, Gałkowska D, Fortuna T, Witczak T: Phenolic profile and antioxidant properties of Polish honeys. Int J Food Sci Tech 2011;46:528-534.
  56. Majtan J, Bohova J, Garcia-Villalba R, Tomas-Barberan FA, Madakova Z, Majtan T, Majtan V, Klaudiny J: Fir honeydew honey flavonoids inhibit TNF-α-induced MMP-9 expression in human keratinocytes: a new action of honey in wound healing. Arch Dermatol Res 2013;305:619-627.
  57. Ker-Woon C, Abd Ghafar N, Hui CK, Mohd Yusof YA, Wan Ngah WZ: The effects of acacia honey on in vitro corneal abrasion wound healing model. BMC Cell Biol 2015;16:1-11.
  58. Ker-Woon C, Abd Ghafar N, Hui CK, Mohd Yusof YA: Effect of acacia honey on cultured rabbit corneal keratocytes. BMC Cell Biol 2014;26:1-9.
  59. Yusof AM, Abd Ghafar N, Kamarudin TA, Hui CK, Yusof YA: Gelam honey potentiates ex vivo corneal keratocytes proliferation with desirable phenotype expression. BMC Complement Altern Med 2016;16:1-9.

Article / Publication Details

First-Page Preview
Abstract of Review Article · Übersichtsarbeit

Published online: November 03, 2016
Issue release date: December 2016

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: https://www.karger.com/CMR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.